These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7252157)

  • 1. Selective desensitization of neutrophils: further studies with 1-O-alkyl-sn-glycero-3-phosphocholine analogues.
    O'Flaherty JT; Lees CJ; Miller CH; McCall CE; Lewis JC; Love SH; Wykle RL
    J Immunol; 1981 Aug; 127(2):731-7. PubMed ID: 7252157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutrophil degranulation: evidence pertaining to its mediation by the combined effects of leukotriene B4, platelet-activating factor, and 5-HETE.
    O'Flaherty JT
    J Cell Physiol; 1985 Feb; 122(2):229-39. PubMed ID: 2981891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophil-degranulating action of 5,12-dihydroxy-6,8,10,14-eicosatetraenoic acid and 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine. Comparison with other degranulating agents.
    O'Flaherty JT; Wykle RL; Lees CJ; Shewmake T; McCall CE; Thomas MJ
    Am J Pathol; 1981 Dec; 105(3):264-9. PubMed ID: 6274199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Desensitization of the neutrophil aggregation response to chemotactic factors.
    O'Flaherty JT; Kreutzer DL; Showell HS; Becker EL; Ward PA
    Am J Pathol; 1978 Dec; 93(3):693-706. PubMed ID: 717543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monocyte aggregation and superoxide anion release in response to formyl-methionyl-leucyl-phenylalanine (FMLP) and platelet-activating factor (PAF).
    Yasaka T; Boxer LA; Baehner RL
    J Immunol; 1982 May; 128(5):1939-44. PubMed ID: 6278021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of human neutrophils with 1-O-hexadecyl/octadecyl-2-acetyl-sn-glycerol-3-phosphorylcholine (platelet activating factor).
    Shaw JO; Pinckard RN; Ferrigni KS; McManus LM; Hanahan DJ
    J Immunol; 1981 Sep; 127(3):1250-5. PubMed ID: 6267133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human leukocyte elastase and cathepsin G are specific inhibitors of C5a-dependent neutrophil enzyme release and chemotaxis.
    Tralau T; Meyer-Hoffert U; Schröder JM; Wiedow O
    Exp Dermatol; 2004 May; 13(5):316-25. PubMed ID: 15140022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in polymorphonuclear leukocyte aggregating responses among several species in response to chemotactic stimulation.
    Oseas RS; Boxer LA; Butterick C; Baehner RL
    J Lab Clin Med; 1980 Aug; 96(2):213-21. PubMed ID: 7400660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet-activating factor and analogues: comparative studies with human neutrophils and rabbit platelets.
    O'Flaherty JT; Salzer WL; Cousart S; McCall CE; Piantadosi C; Surles JR; Hammett MJ; Wykle RL
    Res Commun Chem Pathol Pharmacol; 1983 Feb; 39(2):291-309. PubMed ID: 6844746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1-O-Alkyl-sn-glyceryl-3-phosphorylcholines: a novel class of neutrophil stimulants.
    O'Flaherty JT; Wykle RL; Miller CH; Lewis JC; Waite M; Bass DA; McCall CE; DeChatelet LR
    Am J Pathol; 1981 Apr; 103(1):70-8. PubMed ID: 7223864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Granulocyte activation by endotoxin. II. Role of granulocyte adherence, aggregation, and effect of cytochalasin B, and comparison with formylated chemotactic peptide-induced stimulation.
    Dahinden C; Fehr J
    J Immunol; 1983 Feb; 130(2):863-8. PubMed ID: 6294179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the secretory activity of leukotriene B4 toward rabbit neutrophils.
    Showell HJ; Naccache PH; Borgeat P; Picard S; Vallerand P; Becker EL; Sha'afi RI
    J Immunol; 1982 Feb; 128(2):811-6. PubMed ID: 6274960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substances which aggregate neutrophils. Mechanism of action.
    O'Flaherty JT; Showell HJ; Becker EL; Ward PA
    Am J Pathol; 1978 Jul; 92(1):155-66. PubMed ID: 356621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The roles of degranulation and superoxide anion generation in neutrophil aggregation.
    Kaplan HB; Edelson HS; Friedman R; Weissmann G
    Biochim Biophys Acta; 1982 Sep; 721(1):55-63. PubMed ID: 6289915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxicity and metabolism of alkyl phospholipid analogues in neoplastic cells.
    Hoffman DR; Hoffman LH; Snyder F
    Cancer Res; 1986 Nov; 46(11):5803-9. PubMed ID: 3756924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The sequential release of granule constitutents from human neutrophils.
    Bentwood BJ; Henson PM
    J Immunol; 1980 Feb; 124(2):855-62. PubMed ID: 6153206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective neutrophil desensitization to chemotactic factors.
    O'Flaherty JT; Kreutzer DL; Showell HJ; Vitkauskas G; Becker EL; Ward PA
    J Cell Biol; 1979 Mar; 80(3):564-72. PubMed ID: 457760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of 1-O-alkyl-, 1-O-alk-1'-enyl-, and 1-O-acyl-2-acetyl-sn-glycero-3-phosphoethanolamines and -3-phosphocholines as agonists of the platelet-activating factor family.
    O'Flaherty JT; Tessner T; Greene D; Redman JR; Wykle RL
    Biochim Biophys Acta; 1994 Jan; 1210(2):209-16. PubMed ID: 8280772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Interaction of 1-O-alkyl-2-methoxy-sn-glycero-3-phosphocholine and platelet activating factor with blood and tumor cells].
    Muzia GI; Orlov SM; Berdyshev EV; Kulikov VI
    Biokhimiia; 1994 Jul; 59(7):1054-61. PubMed ID: 7948414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of extracellular calcium and neutrophil degranulation responses to 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine.
    O'Flaherty JT; Swendsen CL; Lees CJ; McCall CE
    Am J Pathol; 1981 Nov; 105(2):107-13. PubMed ID: 6271016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.